![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline:
Kevin M Johnson1, David A Dowe2
1Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut.
Insights
The new American Heart Association/American College of Cardiology guideline better aligns statin therapy with coronary plaque burden compared to older methods. This updated guideline improves accuracy with only a modest increase in patients recommended for statins.
Area of Science:
- Cardiology
- Preventive Medicine
- Medical Imaging
Background:
- Accurate statin therapy assignment is a critical public health concern.
- Previous guidelines, such as the National Cholesterol Education Program (NCEP) Adult Treatment Panel III, have limitations in accurately identifying patients who would benefit from statins.
- The advent of advanced imaging techniques necessitates updated risk assessment strategies.
Purpose of the Study:
- To compare the accuracy of the new American Heart Association and American College of Cardiology guideline (GACR) for cardiovascular risk assessment against the older NCEP guidelines.
- To evaluate whether the GACR guideline more accurately assigns statin therapy based on coronary plaque burden identified via computed tomography angiography.
- To determine the impact of the GACR guideline on the number of patients recommended for statin therapy.
Main Methods:
- Coronary atherosclerosis burden was quantified using a 16-segment model on computed tomography angiography.
- Statin assignment recommendations from the NCEP and GACR guidelines were compared for a cohort of 3,076 subjects.
- The study analyzed discrepancies in statin assignment based on the presence and severity of coronary artery stenosis.
Main Results:
- The GACR guideline demonstrated a sharper increase in statin prescription probability with rising plaque burden compared to NCEP.
- Under NCEP, a significant proportion of patients with substantial coronary stenosis (left main ≥50% stenosis: 59%; other branches ≥50% stenosis: 40%) were undertreated.
- The GACR guideline reduced undertreatment rates (left main ≥50% stenosis: 19%; other branches ≥50% stenosis: 10%) and resulted in a 15% higher proportion of patients assigned to statin therapy.
- Low-density lipoprotein targets in the NCEP guideline were found to significantly degrade its accuracy for statin assignment.
Conclusions:
- The GACR guideline provides a more accurate alignment of statin assignment with the total burden of coronary plaque.
- The updated guideline improves risk stratification for statin therapy without a substantial increase in the overall number of patients treated.
- This study highlights the clinical utility of the GACR guideline in optimizing cardiovascular risk management.
Background:
Accurate assignment of statin therapy is a major public health issue.
Objectives:
The American Heart Association and the American College of Cardiology released a new guideline on the assessment of cardiovascular risk (GACR) to replace the 2001 National Cholesterol Education Program (NCEP) Adult Treatment Panel III recommendations. The aim of this study was to determine which method more accurately assigns statins to patients with features of coronary imaging known to have predictive value for cardiovascular events and whether more patients would be assigned to statins under the new method.
Methods:
The burden of coronary atherosclerosis on computed tomography angiography was measured in several ways on the basis of a 16-segment model. Whether to assign a given patient to statin therapy was compared between the NCEP and GACR guidelines.
Results:
A total of 3,076 subjects were studied (65.3% men, mean age 55.4 ± 10.3 years, mean age of women 58.9 ± 10.3 years). The probability of prescribing statins rose sharply with increasing plaque burden under the GACR compared with the NCEP guideline. Under the NCEP guideline, 59% of patients with ≥50% stenosis of the left main coronary artery and 40% of patients with ≥50% stenosis of other branches would not have been treated. The comparable results for the GACR were 19% and 10%. The use of low-density lipoprotein targets seriously degraded the accuracy of the NCEP guideline for statin assignment. The proportion of patients assigned to statin therapy was 15% higher under the GACR.
Conclusions:
The new American Heart Association/American College of Cardiology guideline matches statin assignment to total plaque burden better than the older guidelines, with only a modest increase in the number of patients who were assigned statins.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:30Atherosclerosis I: Introduction
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
01:26Coronary Artery Disease IV: Preventive Measures